Bolt Biotherapeutics Inc (BOLT)

$5.64 -0.13 (-2.25%)
Market Cap 11.06M
Revenue (ttm) 7.69M
Net Income (ttm) -63.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -820.81%
Debt to Equity Ratio 0.00
Volume 39,800
Avg Vol 23,912
Day's Range N/A - N/A
Shares Out 1.92M
Stochastic %K 20%
Beta 0.92
Analysts Sell
Price Target $40.00

Company Profile

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company dBDC-3042, develops dan agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer; and BDC-4182, an next-generation boltbody technology platform that targets claudin 18.2, which is overexpressed in gastric/gastroesophageal junction cancer, pancreat...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 665 9295
Address:
900 Chesapeake Drive, Redwood City, United States
Golibajje
Golibajje Jun. 17 at 7:54 PM
$BOLT This will fly like $LYRA when the results are announced! $58M cash.. trading at $11M!! Only 1.4m shares free float
0 · Reply
rp6577
rp6577 Jun. 17 at 5:24 PM
$BOLT data update due within the next couple of weeks. Also they are actually seeking a partner, which could be announced at any moment. Small float post reverse split (compliance to be regained shortly) and it has been severely beaten up. Market cap way below cash levels $XBI $LABU
0 · Reply
rp6577
rp6577 Jun. 17 at 1:52 PM
$BOLT added today
0 · Reply
makedatbread88
makedatbread88 Jun. 16 at 2:54 PM
$BOLT recent reverse split, low float, has a catalyst “The BDC-3042 Phase 1 trial has completed enrollment in its highest dose cohort with no dose-limiting toxicities, with results expected in Q2 2025.” https://www.stocktitan.net/news/BOLT/bolt-biotherapeutics-reports-fourth-quarter-and-full-year-2024-bth28cr5s08b.html
0 · Reply
Golibajje
Golibajje Jun. 12 at 11:33 PM
$BOLT buying 1500 shares every day. This will pop one day 😀 $58M cash.. no debt!! Trading at $12M $PLRZ $TNXP
0 · Reply
Great7
Great7 Jun. 12 at 1:33 PM
$BOLT and $TNXP rebound
0 · Reply
Great7
Great7 Jun. 11 at 10:49 AM
$TNXP $BOLT
0 · Reply
topstockalerts
topstockalerts Jun. 10 at 6:22 PM
$BOLT this setup continues to provide opportunities.. stay tuned!👀👀
0 · Reply
KlausSchwab
KlausSchwab Jun. 10 at 5:40 PM
$ALT double digits in near future? $BOLT strong buy
1 · Reply
Great7
Great7 Jun. 10 at 5:36 PM
$TNXP and $BOLT Goals coming here✈️😀👍
0 · Reply
Latest News on BOLT
Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025, 4:05 PM EDT - 5 weeks ago

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

May 8, 2025, 8:00 AM EDT - 5 weeks ago

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Apr 30, 2025, 4:05 PM EDT - 6 weeks ago

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Apr 25, 2025, 1:00 PM EDT - 7 weeks ago

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Mar 25, 2025, 4:30 PM EDT - 3 months ago

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Mar 24, 2025, 4:20 PM EDT - 3 months ago

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Feb 25, 2025, 4:05 PM EST - 4 months ago

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Feb 11, 2025, 4:05 PM EST - 4 months ago

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Nov 7, 2024, 10:00 AM EST - 7 months ago

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

Sep 6, 2024, 11:00 AM EDT - 10 months ago

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

Bolt Biotherapeutics Announces Changes to its Board of Directors

Sep 4, 2024, 4:05 PM EDT - 10 months ago

Bolt Biotherapeutics Announces Changes to its Board of Directors

Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm

Sep 4, 2024, 11:00 AM EDT - 10 months ago

Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm

BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Sep 2, 2024, 11:11 AM EDT - 10 months ago

BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions

Sep 2, 2024, 11:00 AM EDT - 10 months ago

Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Aug 31, 2024, 11:25 AM EDT - 10 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm

Aug 31, 2024, 11:00 AM EDT - 10 months ago

Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Aug 29, 2024, 8:49 PM EDT - 10 months ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

The Schall Law Firm Urges Investors To Join A Lawsuit For Securities Fraud Against Bolt Biotherapeutics Inc

Aug 28, 2024, 11:00 AM EDT - 10 months ago

The Schall Law Firm Urges Investors To Join A Lawsuit For Securities Fraud Against Bolt Biotherapeutics Inc

A Case Has Been Filed Against Bolt Biotherapeutics Inc For Securities Law Infractions And Stakeholders Are Encouraged To Contact The Schall Law Firm

Aug 27, 2024, 11:00 AM EDT - 10 months ago

A Case Has Been Filed Against Bolt Biotherapeutics Inc For Securities Law Infractions And Stakeholders Are Encouraged To Contact The Schall Law Firm

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 13, 2024, 4:05 PM EDT - 11 months ago

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

BOLT Investors Have Opportunity to Actively Participate Bolt Biotherapeutics, Inc.

Jul 26, 2024, 10:00 AM EDT - 11 months ago

BOLT Investors Have Opportunity to Actively Participate Bolt Biotherapeutics, Inc.

BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc.

Jul 25, 2024, 10:00 AM EDT - 11 months ago

BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc.

Faruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on September 3, 2024 in Bolt Lawsuit

Jul 19, 2024, 11:10 AM EDT - 11 months ago

Faruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on September 3, 2024 in Bolt Lawsuit

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bolt Biotherapeutics, Inc. (BOLT)

Jul 3, 2024, 4:47 PM EDT - 1 year ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Jun 24, 2024, 3:36 PM EDT - 1 year ago

Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call Transcript

May 17, 2024, 8:37 PM EDT - 1 year ago

Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call Transcript

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Mar 21, 2024, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Golibajje
Golibajje Jun. 17 at 7:54 PM
$BOLT This will fly like $LYRA when the results are announced! $58M cash.. trading at $11M!! Only 1.4m shares free float
0 · Reply
rp6577
rp6577 Jun. 17 at 5:24 PM
$BOLT data update due within the next couple of weeks. Also they are actually seeking a partner, which could be announced at any moment. Small float post reverse split (compliance to be regained shortly) and it has been severely beaten up. Market cap way below cash levels $XBI $LABU
0 · Reply
rp6577
rp6577 Jun. 17 at 1:52 PM
$BOLT added today
0 · Reply
makedatbread88
makedatbread88 Jun. 16 at 2:54 PM
$BOLT recent reverse split, low float, has a catalyst “The BDC-3042 Phase 1 trial has completed enrollment in its highest dose cohort with no dose-limiting toxicities, with results expected in Q2 2025.” https://www.stocktitan.net/news/BOLT/bolt-biotherapeutics-reports-fourth-quarter-and-full-year-2024-bth28cr5s08b.html
0 · Reply
Golibajje
Golibajje Jun. 12 at 11:33 PM
$BOLT buying 1500 shares every day. This will pop one day 😀 $58M cash.. no debt!! Trading at $12M $PLRZ $TNXP
0 · Reply
Great7
Great7 Jun. 12 at 1:33 PM
$BOLT and $TNXP rebound
0 · Reply
Great7
Great7 Jun. 11 at 10:49 AM
$TNXP $BOLT
0 · Reply
topstockalerts
topstockalerts Jun. 10 at 6:22 PM
$BOLT this setup continues to provide opportunities.. stay tuned!👀👀
0 · Reply
KlausSchwab
KlausSchwab Jun. 10 at 5:40 PM
$ALT double digits in near future? $BOLT strong buy
1 · Reply
Great7
Great7 Jun. 10 at 5:36 PM
$TNXP and $BOLT Goals coming here✈️😀👍
0 · Reply
petoss
petoss Jun. 10 at 5:11 PM
$BOLT some data soon, target 40+ here
0 · Reply
petoss
petoss Jun. 10 at 4:41 PM
$BOLT 50mil cash, thats 4x here and float now 2mil .. Tang Capital Management IN - remember TOP squuuze ??
0 · Reply
topstockalerts
topstockalerts Jun. 10 at 1:53 PM
$BOLT buyers stepping in.. ✅✅
0 · Reply
rp6577
rp6577 Jun. 10 at 1:45 PM
$BOLT 🔥🔥
0 · Reply
Drugtrade
Drugtrade Jun. 10 at 1:41 PM
$BOLT float now ~2m just need some kind of pipeline update to push it .. added 100 shares
1 · Reply
Great7
Great7 Jun. 10 at 12:56 PM
$BOLT
0 · Reply
PenkeTrading
PenkeTrading Jun. 10 at 12:30 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Bolt Biotherapeutics. Is that bullish or bearish? $BOLT #RsiOverbought #NASDAQ
1 · Reply
TwongStocks
TwongStocks Jun. 9 at 8:30 PM
Today's NASDAQ reverse split results. All closed red today: $DUO 1 for 16 Previous close $0.20, $3.20 split-adjusted Today's close $2.76 🔴Down 13.75% $NKTR 1 for 15 Previous close $0.666, $9.99 split-adjusted Today's close $8.79 🔴Down 12.01% $PXLW 1 for 12 Previous close $0.504, $6.048 split-adjusted Today's close $5.84 🔴Down 3.44% $AEMD 1 for 8 Previous close $0.3299, $2.6392 split-adjusted Today's close $2.27 🔴Down 13.99% $BOLT 1 for 20 Previous close $0.323, $6.46 split-adjusted Today's close $6.14 🔴Down 4.95%
2 · Reply
Great7
Great7 Jun. 9 at 3:22 PM
$BOLT He puts a position at $6 and then takes off
0 · Reply
UnicornPicks
UnicornPicks Jun. 9 at 2:57 PM
$SNPX $BOLT $CRKN $ELAB were some free ideas we shared this morning.. One hit +37%! Let's goooo
0 · Reply
TwongStocks
TwongStocks Jun. 9 at 11:40 AM
Five reverse splits on NASDAQ today. Trading resumes at 9:00am ET. $DUO 1 for 16. Will reduce outstanding shares from 62,472,674 to approx 3,904,565. $NKTR 1 for 15. Will reduce outstanding shares from approx 186.1m to approx 12.4m. $PXLW 1 for 12. Will reduce outstanding shares from approx 63m to approx 5.25m. $AEMD 1 for 8. Will reduce outstanding shares from approx 16m to approx 2m. $BOLT 1 for 20. Will reduce outstanding shares from 38.3m to approx 1.9m.
0 · Reply
TwongStocks
TwongStocks Jun. 6 at 9:05 PM
For Monday, I am currently tracking 5 reverse splits on NASDAQ. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Monday morning. $DUO 1 for 16. Will reduce outstanding shares from 62,472,674 to approx 3,904,565. $NKTR 1 for 15. Will reduce outstanding shares from approx 186.1m to approx 12.4m. $PXLW 1 for 12. Will reduce outstanding shares from approx 63m to approx 5.25m. $AEMD 1 for 8. Will reduce outstanding shares from approx 16m to approx 2m. $BOLT 1 for 20. Will reduce outstanding shares from 38.3m to approx 1.9m.
1 · Reply